Receptor tyrosine kinase signalling as a target for cancer intervention strategies
about
Direct association of Sprouty-related protein with an EVH1 domain (SPRED) 1 or SPRED2 with DYRK1A modifies substrate/kinase interactionsCharacterisation of HER heterodimers in breast cancer using in situ proximity ligation assayInvestigation of the expression of the EphB4 receptor tyrosine kinase in prostate carcinoma.Thyroid Hormones as Renal Cell Cancer RegulatorsMolecular characterizations of glioblastoma, targeted therapy, and clinical results to dateCD44 as a potential diagnostic tumor markerDevelopment of Cell-SELEX Technology and Its Application in Cancer Diagnosis and TherapyPazopanib in the treatment of soft tissue sarcomaNucleic acid aptamers in cancer medicine.Identifying Significant Features in Cancer Methylation Data Using Gene Pathway Segmentation.Membrane fixation of vascular endothelial growth factor receptor 1 ligand-binding domain is important for vasculogenesis and angiogenesis in mice.A quantitative study of the recruitment potential of all intracellular tyrosine residues on EGFR, FGFR1 and IGF1R.Novel insights into G protein and G protein-coupled receptor signaling in cancerPotential therapeutics specific to c-MET/RON receptor tyrosine kinases for molecular targeting in cancer therapy.Targeted Therapy of Cancer Using Photodynamic Therapy in Combination with Multi-faceted Anti-Tumor ModalitiesVenus kinase receptors control reproduction in the platyhelminth parasite Schistosoma mansoniFibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.A network-based biomarker approach for molecular investigation and diagnosis of lung cancer.Genetic association analysis of the RTK/ERK pathway with aggressive prostate cancer highlights the potential role of CCND2 in disease progressionSmall-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapiesBioengineering strategies for designing targeted cancer therapiesChange or die: targeting adaptive signaling to kinase inhibition in cancer cells.Loss of function of e-cadherin in embryonic stem cells and the relevance to models of tumorigenesisThe role of the breast cancer resistance protein (ABCG2) in the distribution of sorafenib to the brain.Leucine motif-dependent tyrosine autophosphorylation of type III receptor tyrosine kinases.Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism.ABC transporters in multi-drug resistance and ADME-Tox of small molecule tyrosine kinase inhibitors.Tyrosine phosphorylation profiling via in situ proximity ligation assay.Unfolded protein response is required in nu/nu mice microvasculature for treating breast tumor with tunicamycin.Growth factors and myometrium: biological effects in uterine fibroid and possible clinical implicationsGrowth regulation via insulin-like growth factor binding protein-4 and -2 in association with mutant K-ras in lung epithelia.Design, Synthesis, and Biological Evaluation of Novel Imidazo[1,2-a]pyridine Derivatives as Potent c-Met Inhibitors.Morphological and molecular characteristics of HER2 amplified urothelial bladder cancerAntagonists of growth hormone-releasing hormone inhibit growth of androgen-independent prostate cancer through inactivation of ERK and Akt kinasesBone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy.Computational Identification of Key Regulators in Two Different Colorectal Cancer Cell Lines.Macropinocytosis of the PDGF β-receptor promotes fibroblast transformation by H-RasG12V.Combination therapy with HSP90 inhibitor 17-DMAG reconditions the tumor microenvironment to improve recruitment of therapeutic T cells.N-acetylglucosaminyl 1-phosphate transferase: an excellent target for developing new generation breast cancer therapeuticGrowth factor receptors in helminth parasites: signalling and host-parasite relationships.
P2860
Q24297221-F3532A33-336F-4995-B542-D8510CFEEAB8Q24337937-92109FEF-C6E6-4D3A-A8A4-F3F9ED6BCA34Q24815816-5098EF42-8A28-4917-87D9-7C5B51002F2DQ26748991-BBD4DCF9-9620-4ACD-B02C-E09269EA6A8FQ26822717-8F01177F-84C8-40D1-8D47-9BC70F1A52C0Q26866085-FACF497B-29C2-4037-80CA-1CFDB720C2F8Q28080168-0395DA39-5FD5-44B4-8D49-D4FA2070B5A9Q28269229-45E843D1-7A23-4184-8082-FE04DABAEAE7Q30854890-2B304D4C-2B37-4B18-9DEB-FBD030C4B265Q31133907-2226C6A4-5F43-4A0F-BFEA-BD8FA1B338ABQ33551759-36DC9F83-3578-48FE-9951-747AC3050546Q33610352-32353200-3022-486F-99FC-EF3F32B6116DQ33612895-FD35CCE8-3E11-4DA9-993D-DE19D5156224Q33652455-BBEE4C37-F9B5-4577-A854-D0C4E7C67D3CQ33664307-E12B3A28-D98D-4B84-A174-A74BF05F69EFQ33686019-88B98C98-F4CA-40D3-B134-CDC121506B29Q33783047-E9E7F896-BCDD-420F-AA5A-6FDE48477319Q33787452-86378567-B564-4296-A3D1-15017CE7DD4FQ33866927-EE61F0EB-8C0C-4852-B6DD-C3119F626C8CQ34158454-1FEBFEBB-E2CB-49E9-A7B9-531970388631Q34194191-601F519F-DDEB-48D8-970D-A6DDA5FFB043Q34225871-22634532-3C9D-4B14-8AC7-6A5697B44F74Q34423998-E2A3A783-BE6A-4866-B647-4F2F6FC3A61EQ34458602-EB15E3E6-D382-4074-97BB-3D96518FF9CBQ34595463-3134FE29-536D-436A-9E57-CF534F85682BQ34948215-AF610046-9584-4CDC-BE4F-6C5CB370CA90Q35171274-9E5DBC30-7A61-4B59-B4B3-4E58A27C9074Q35188112-0F4C6C10-82B2-40E2-B29C-1D122896866BQ35309992-472061C7-3FAE-4D65-9E63-847762BE074CQ35328276-E4D59B75-7152-4185-B66A-686AE5DA0E5EQ35607282-522820EF-330B-4493-9B4C-95BF581734FEQ35615162-B2659BC6-EDCF-4F5C-A61D-0AC1EBF413F8Q35698114-6592FFAA-DCF8-4039-9D52-A281FF0C1708Q35749794-6F119DBC-9392-4489-BF29-1CFABA1C7D59Q35894540-0B47773B-D153-486B-9974-7BEB710A1E95Q35993392-EB33D4AC-F211-4628-ADB5-3DC7F412AEFBQ36066649-C29AEF5C-4963-4119-8A2F-941B03659625Q36074307-BE1CE301-ED57-4FBC-9D92-65B8717D0DE4Q36156434-6E7C659F-0285-41A1-807E-F2486DF75228Q36437255-8FE0E381-8F32-4A0A-B0D3-C3D38196E985
P2860
Receptor tyrosine kinase signalling as a target for cancer intervention strategies
description
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2001
@ast
im September 2001 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: September 2001)
@en
vedecký článok (publikovaný 2001-09)
@sk
vědecký článek publikovaný v roce 2001
@cs
wetenschappelijk artikel (gepubliceerd in 2001-09)
@nl
наукова стаття, опублікована у вересні 2001
@uk
مقالة علمية (نشرت في سبتمبر 2001)
@ar
name
Receptor tyrosine kinase signalling as a target for cancer intervention strategies
@ast
Receptor tyrosine kinase signalling as a target for cancer intervention strategies
@en
Receptor tyrosine kinase signalling as a target for cancer intervention strategies
@nl
type
label
Receptor tyrosine kinase signalling as a target for cancer intervention strategies
@ast
Receptor tyrosine kinase signalling as a target for cancer intervention strategies
@en
Receptor tyrosine kinase signalling as a target for cancer intervention strategies
@nl
prefLabel
Receptor tyrosine kinase signalling as a target for cancer intervention strategies
@ast
Receptor tyrosine kinase signalling as a target for cancer intervention strategies
@en
Receptor tyrosine kinase signalling as a target for cancer intervention strategies
@nl
P2093
P3181
P356
P1476
Receptor tyrosine kinase signalling as a target for cancer intervention strategies
@en
P2093
P304
P3181
P356
10.1677/ERC.0.0080161
P407
P577
2001-09-01T00:00:00Z